SCHEMBL6530104

SCHEMBL6530104

O=C1CC(=O)c2cc(Br)ncc2N1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 2/20 0.44
PDE3A Q14432 2/20 0.44
AHR P35869 4/20 0.39
CMA1 P23946 2/20 0.39
GSK3B P49841 5/20 0.33
CDK5 Q00535 5/20 0.33
CDK5R1 Q15078 4/20 0.33
GSK3A P49840 3/20 0.33
TDP2 O95551 2/20 0.33
KDR P35968 3/20 0.32
CCNB2 O95067 3/20 0.32
CDK1 P06493 3/20 0.32
CCNB1 P14635 3/20 0.32
CCNB3 Q8WWL7 3/20 0.32
PDK2 Q15119 1/20 0.32
SMYD3 Q9H7B4 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
ABL1 P00519 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25300707 0.79 AHR (0.49) PDE3BPDE3AAHRCMA1GSK3B
SCHEMBL22904233 0.72 TDP2 (0.51) AHRCMA1TDP2
SCHEMBL30780152 0.72 TDP2 (0.51) AHRCMA1TDP2
SCHEMBL6533332 0.70 PDE3B (0.37) PDE3BPDE3ASMYD3
SCHEMBL28498877 0.69 PDE3B (0.44) PDE3BPDE3AAHRCMA1GSK3B
SCHEMBL30656157 0.69 PDE3B (0.44) PDE3BPDE3AAHRCMA1GSK3B
SCHEMBL30543229 0.69 PDE3B (0.44) PDE3BPDE3AAHRCMA1GSK3B
SCHEMBL25433296 0.69 PDE3B (0.44) PDE3BPDE3AAHRCMA1GSK3B
SCHEMBL31694058 0.68 CYP11B1 (0.46) PDE3BPDE3ACYP11B1CYP11B2
SCHEMBL30543250 0.67 PDE3B (0.56) PDE3BPDE3AAHRCMA1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1608377-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF FAB I AND FURTHER ANTIBIOTICS Affinium Pharmaceuticals, Inc. (CA) 2005-12-28 EP disclosed
EP-1575951-A1 HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY Affinium Pharmaceuticals, Inc. (CA) 2005-09-21 EP disclosed
WO-2004082586-A2 PHAMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF FAB I AND FURTHER ANTIBIOTICS AFFINIUM PHARMACEUTICALS, INC. (US) 2004-09-30 WO disclosed
WO-2004052890-A1 HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY AFFINIUM PHARMACEUTICALS, INC. (CA) 2004-06-24 WO disclosed